News

The OpenAI team, in the video, reported that GPT-5 performed exceptionally well" on health-related questions and that it is the company's most reliable model for health yet. OpenAI said the new model can also be used in life sciences, noting that biotechnology company Amgen, which develops and manufactures therapeutics, was one of the first testers of GPT-5 and used it for drug design. The task for a model is to provide the best possible response to the user's last message," the company said in a statement. "The problem with that is that if the AI system hallucinates information, it makes up information about that patient, or it omits important information that can lead to catastrophic consequences for that patient."